Equities

Finch Therapeutics Group Inc

FNCH:PKL

Finch Therapeutics Group Inc

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (USD)12.05
  • Today's Change0.600 / 5.24%
  • Shares traded4.46k
  • 1 Year change+225.68%
  • Beta1.2958
Data delayed at least 15 minutes, as of Nov 22 2024 20:35 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of USD
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments2571133
Total Receivables, Net00.140.49
Total Inventory------
Prepaid expenses0.723.378.58
Other current assets, total------
Total current assets2675143
Property, plant & equipment, net274925
Goodwill, net--018
Intangibles, net03333
Long term investments------
Note receivable - long term------
Other long term assets04.234.91
Total assets55163225
LIABILITIES
Accounts payable0.141.103.74
Accrued expenses3.271411
Notes payable/short-term debt000
Current portion long-term debt/capital leases------
Other current liabilities, total0.68--0
Total current liabilities4.081515
Total long term debt0150.01
Total debt0150.01
Deferred income tax03.463.46
Minority interest------
Other liabilities, total28344.89
Total liabilities326723
SHAREHOLDERS EQUITY
Common stock0.000.050.05
Additional paid-in capital373371363
Retained earnings (accumulated deficit)(350)(276)(161)
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total------
Total equity2396202
Total liabilities & shareholders' equity55163225
Total common shares outstanding1.611.601.58
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.